Bodycote PT Raised to $9.10 at Credit Suisse (BOY)
Analysts at Credit Suisse increased their price target on shares of Bodycote (LON: BOY) from $7.58 (500 GBX) to $9.10 (600 GBX) in a research report issued to clients and investors on Wednesday. The firm currently has an “outperform” rating on the stock.
A number of other analysts have also recently weighed in on BOY. Analysts at Investec upgraded shares of Bodycote to a “buy” rating in a research note to investors on Wednesday. They now have a $9.63 price target on the stock. Separately, analysts at Oriel Securities Ltd reiterated a “buy” rating on shares of Bodycote in a research note to investors on Monday. They now have a $8.31 price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Bodycote in a research note to investors on Tuesday, January 8th. They now have a $8.46 price target on the stock.
Shares of Bodycote traded up 7.42% during mid-day trading on Wednesday, hitting GBX 543.00. Bodycote has a 52 week low of GBX 300.50 and a 52 week high of GBX 527.50. The stock’s 50-day moving average is currently GBX 384.0. The company’s market cap is £1.023 billion.
Bodycote plc (Bodycote) is a of specialised plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
